A new study published in Nature Communications presents a genome-wide map of the genetic signals that influence protein levels in human skin, offering a more detailed view of how inherited DNA variation may shape skin biology and contribute to disease. Led by Y. Sun, W. Li, Z. Wang and colleagues, the research focuses on protein quantitative trait loci, or pQTLs—genetic variants associated with measurable differences in the abundance of specific proteins. By connecting genetic variation to the molecular landscape of skin, the work provides a framework for tracing disease risk from DNA to proteins and, ultimately, to biological mechanisms that may be accessible to treatment.
The skin is often described as the body’s largest organ, but its complexity extends far beyond its visible surface. It contains multiple layers, specialized cells, structural fibers, immune defenses, signaling molecules and biochemical barriers that must operate together to protect the body from the outside world. Many skin disorders arise when these systems become unbalanced. Genetics can influence the production, stability, transport or activity of proteins involved in inflammation, tissue repair, pigmentation, barrier function and cellular communication. Yet identifying the precise molecular steps between a DNA variant and a clinical condition has remained difficult. A pQTL map can help bridge that gap by revealing which genetic differences are associated with changes in protein abundance.
Genome-wide association studies have identified thousands of variants linked to human traits and diseases, but most of these variants do not directly alter the structure of a protein. Instead, they may affect when, where or how strongly a gene is expressed, or they may influence regulatory regions that control neighboring genes. This creates a major interpretive challenge: a disease-associated variant may be located near one gene while exerting its strongest biological effect on another. Protein-level analysis provides an additional layer of evidence. If a variant is associated with both a skin disorder and the abundance of a particular protein in skin, researchers can begin to test whether that protein is part of the causal pathway rather than merely a bystander.
The study’s central resource is a genome-wide catalogue of skin-associated pQTLs. Such a catalogue is generated by combining genetic data with measurements of proteins present in skin samples. Researchers then use statistical models to identify variants whose presence correlates with higher or lower levels of particular proteins. The most informative signals may act locally, affecting a gene close to the variant, or remotely, influencing a protein encoded elsewhere in the genome. These associations can reflect regulatory control, altered protein processing, differences in cellular composition or other molecular effects. Careful analysis is therefore required to distinguish genuine biological relationships from correlations created by technical variation or the mixture of different cell types within skin tissue.
By mapping these relationships in human skin rather than relying exclusively on blood or other accessible tissues, the researchers address an important limitation in biomedical genetics. A genetic variant may have different consequences in different organs because genes are regulated according to tissue-specific environments. A protein that appears unchanged in circulation may be strongly altered in skin, where it could influence epidermal renewal, immune surveillance or the integrity of the protective barrier. Conversely, a signal detected in blood may not accurately represent what is occurring in a lesion or in healthy tissue. Tissue-specific pQTL data can therefore make genetic studies more biologically precise, helping researchers determine which molecular effects are relevant to the organ affected by disease.
The analysis also establishes mechanistic links between genetic regulators and skin disorders. In this context, a mechanistic link means more than a statistical association. It suggests a chain of evidence in which a genetic variant influences protein abundance, the protein participates in a biological pathway, and that pathway is connected to disease susceptibility or progression. Researchers commonly strengthen such links through methods such as colocalization analysis, which tests whether genetic signals for protein abundance and disease are likely driven by the same variant, and Mendelian randomization, which uses inherited genetic differences to examine whether changes in a protein may causally affect a trait. These approaches cannot replace laboratory experiments, but they can prioritize the most compelling targets for functional validation.
The findings could be particularly valuable for disorders in which inflammation, barrier disruption and abnormal tissue remodeling interact. Conditions such as psoriasis, atopic dermatitis, acne, vitiligo and skin cancers involve distinct biological processes, but all are shaped by networks of proteins rather than by single molecular switches. A skin pQTL map may help separate proteins that actively contribute to disease from those that simply reflect tissue damage. It may also reveal why the same treatment works well for some patients but not others. If inherited variants alter the baseline abundance or responsiveness of a therapeutic target, genetic information could eventually help guide treatment selection, dosing or the design of combination therapies.
The work may also accelerate drug discovery. Proteins associated with disease through human genetic evidence are often considered more promising therapeutic targets because their biological relevance is supported before a drug is developed. A pQTL signal can identify proteins that might be increased, reduced, blocked or stabilized to influence disease pathways. It can also highlight potential safety concerns if a target affects multiple tissues or biological functions. Importantly, the map can expose regulatory effects that conventional gene-expression studies miss. RNA levels and protein levels are related but not interchangeable: messenger RNA can be rapidly degraded, translation can be regulated, and proteins can be modified or removed after they are produced. Measuring proteins therefore brings genetic research closer to the functional machinery of the cell.
The researchers’ resource is likely to serve as a foundation for future studies that combine genomics, proteomics, single-cell analysis and clinical data. Future work will need to determine whether the reported associations hold across diverse populations, ages, skin sites and disease states, since genetic effects can vary with ancestry, environment and tissue context. Experimental studies will also be essential to test how candidate variants alter cellular behavior and whether changing the corresponding proteins improves disease outcomes. Even with those questions remaining, genome-wide pQTL mapping marks a significant step toward a more connected model of skin biology—one that follows the path from inherited variation to protein regulation and from molecular change to disease. The study turns the skin into a more readable genetic and biochemical landscape, potentially bringing researchers closer to treatments designed around mechanisms rather than symptoms.
Subject of Research: Genome-wide protein quantitative trait locus mapping in human skin and its links to skin disorders
Article Title: Genome-wide pQTL mapping in human skin identifies specific genetic regulators and mechanistic links to skin disorders
Article References: Sun, Y., Li, W., Wang, Z. et al. “Genome-wide pQTL mapping in human skin identifies specific genetic regulators and mechanistic links to skin disorders.” Nature Communications (2026). https://doi.org/10.1038/s41467-026-76575-4
Image Credits: AI Generated
DOI: 10.1038/s41467-026-76575-4
Keywords: human skin, pQTL mapping, proteomics, genetic regulation, skin disorders, genomics, protein biomarkers, disease mechanisms
Tags: DNA variants influencing skin biologygenetic architecture of skin disordersgenetic regulation of skin proteinsgenome-wide skin pQTL mappinginherited DNA variation and skin functionmolecular mechanisms of skin diseasesmolecular pathways in skin healthprotein quantitative trait loci in dermatologyskin disease biomarkers and therapeutic targetsskin disorder geneticsskin proteomics and disease riskskin tissue genetic studies
